Liquidia (LQDA) Inventory Average (2024 - 2026)
Liquidia's (LQDA) quarterly Inventory Average came in at $26.2 million in Q1 2026, up 3189.81% year-on-year from $795000.0 in Q1 2025, and up 8.22% quarter-over-quarter from $24.2 million in Q4 2025.
Liquidia (LQDA) Inventory Average (2024 - 2026) Analysis & Trends
Liquidia's Inventory Average history runs 3 years deep, the most recent figure standing at $26.2 million for Q1 2026.
- On a quarterly basis, Inventory Average rose 3189.81% year-over-year to $26.2 million in Q1 2026; TTM through Mar 2026 was $26.2 million, a 3189.81% increase from a year earlier, with the FY2025 full-year figure at $12.0 million, changed N/A from the prior year.
- Inventory Average rose to $26.2 million in Q1 2026 per LQDA's latest filing, from $24.2 million in the prior quarter.
- Across five years, Inventory Average topped out at $26.2 million in Q1 2026 and bottomed at $139500.0 in Q4 2024.
- The 3-year median for Inventory Average is $4.6 million (2024), against an average of $10.0 million.
- Biggest YoY gain for Inventory Average was 17224.73% in 2025; the steepest drop was 27.17% in 2025.
- Year by year, Inventory Average stood at $139500.0 in 2024, then soared by 17224.73% to $24.2 million in 2025, then climbed by 8.22% to $26.2 million in 2026.
- Per Business Quant, the three latest LQDA Inventory Average figures stand at $26.2 million (Q1 2026), $24.2 million (Q4 2025), and $15.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 26.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.15 Mn |
| Dec 31, 2025 | 24.17 Mn |
| Sep 30, 2025 | 15.49 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 795,000.00 |
| Dec 31, 2024 | 139,500.00 |
| Sep 30, 2024 | 3.62 Mn |
| Jun 30, 2024 | 5.35 Mn |